CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma
Conditions
- B-Cell Non-Hodgkin Lymphoma-Recurrent
- Diffuse Large B-Cell Lymphoma-Recurrent
- Follicular Lymphoma-Recurrent
- High Grade B-Cell Lymphoma-Recurrent
- Primary Mediastinal Large B-Cell Lymphoma-Recurrent
- Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma-Recurrent
- B-Cell Non-Hodgkin Lymphoma-Refractory
- Diffuse Large B-Cell Lymphoma-Refractory
- Follicular Lymphoma-Refractory
- High Grade B-Cell Lymphoma-Refractory
- Primary Mediastinal Large B-Cell Lymphoma-Refractory
- Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma-Refractory
Interventions
- PROCEDURE: Biopsy
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Computed Tomography
- DRUG: Golcadomide
- PROCEDURE: Positron Emission Tomography
- BIOLOGICAL: Rituximab
Sponsor
Nathan Denlinger
Collaborators